Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
141.44
-2.77 (-1.92%)
Nov 20, 2024, 4:00 PM EST - Market closed
Glaukos Market Cap
Glaukos has a market cap or net worth of $7.79 billion as of November 21, 2024. Its market cap has increased by 156.39% in one year.
Market Cap
7.79B
Enterprise Value
7.69B
1-Year Change
156.39%
Ranking
Category
Stock Price
$141.44
Market Cap Chart
Since June 25, 2015, Glaukos's market cap has increased from $999.60M to $7.79B, an increase of 679.78%. That is a compound annual growth rate of 24.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 7.80B | 101.04% |
| Dec 29, 2023 | 3.88B | 86.16% |
| Dec 30, 2022 | 2.08B | -0.00% |
| Dec 31, 2021 | 2.08B | -38.42% |
| Dec 31, 2020 | 3.38B | 68.22% |
| Dec 31, 2019 | 2.01B | -0.60% |
| Dec 31, 2018 | 2.02B | 128.25% |
| Dec 29, 2017 | 886.60M | -22.95% |
| Dec 30, 2016 | 1.15B | 45.18% |
| Dec 31, 2015 | 792.60M | -20.71% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teleflex | 8.70B |
| Roivant Sciences | 8.36B |
| Chemed | 8.25B |
| The Ensign Group | 8.23B |
| Bruker | 8.09B |
| Repligen | 7.78B |
| Ascendis Pharma | 7.43B |
| Legend Biotech | 7.36B |